Unlike medications, which affect the entire body as they pass through the blood-brain barrier, TMS therapy targets depression at the source.
For those diagnosed with depression, specific areas of the brain are known to be underactive. Stimulating these areas can improve the brain’s ability to regulate mood.
Akbari, Hesam & Sadiq, Muhammad Tariq & Rehman, Ateeq. (2021). Classification of normal and depressed EEG signals based on centered correntropy of rhythms in empirical wavelet transform domain. Health Information Science and Systems. 9. 10.1007/s13755-021-00139-7.
Expertise + Dedication = Innovation
Deep Transcranial Magnetic Stimulation, or dTMS, is an FDA-approved, non-invasive treatment option that offers long-term relief for major depression. This revolutionary treatment uses magnetic fields to stimulate areas of the brain that control mood and are underactive in people with depression. This technology is available at Katie’s Way. With dTMS you can regain a sense of well-being and enjoy a better quality of life in just a few weeks.
Katie’s Way uses BrainsWay Deep TMS technology, which has been tested in over 60+ clinical studies for various indications in leading institutions worldwide. The FDA has cleared this technology for clinical use in Major Depressive Disorder, and it is currently available in the US, Europe, and South America*. Over 15,000 patients have already been treated with BrainsWay, including hundreds of patients at Katie’s Way!
Katie’s Way is a proud supporter of our nation’s military and their families. With our proximity to military institutions, Katie’s Way has the privilege of being a service provider to active duty personnel and their dependents. Katie’s Way accepts Tricare. Deep transcranial magnetic stimulation is an excellent treatment option for the military and community suffering from Depression (MDD) or Post Traumatic Stress Disorder (PTSD) with associated MDD.
Like: Talk therapy & Antidepressants
BrainsWay deep TMS is approved for patients aged 18 or older who have been diagnosed with major depressive disorder (MDD).
In real-life clinical settings*, the treatment was proven to be effective for 3 out of 4 patients, with a 51% remission rate and 75% response rate and has been used to help PTSD as well.
Studies have shown the treatment to be effective for patients with depression, no matter how many other medications were tried in the current depressive episode.
BrainsWay is a non-invasive procedure, which eliminates the need for hospitalization. Patients may experience minor side effects such as headaches or minor pain at the site of the treatment. However, this is usually brief and ceases after the first few sessions.
BrainsWay uses Deep TMS technology, which has been tested in over 60 clinical studies for various indications in leading institutions worldwide. The FDA has cleared this technology for clinical use in Major Depressive Disorder and it is currently available in the US, Europe and South America*. Over 15,000 patients have already been treated with BrainsWay.
The treatment integrates seamlessly into your routine. During each session, you are comfortably seated on a chair and a cushioned helmet is placed over your head. The helmet uses magnetic fields to stimulate the targeted brain area and improve depressive symptoms. The procedure requires daily sessions of 20 minutes for 4-6 weeks. As the treatment does not require hospitalization or anesthesia, and entails no memory loss and no systemic side effects, you can return to your normal routine after each session.